My Pathway: An Open Label Phase IIa Study Evaluating Trastuzumab/Pertuzumab, Erl
- This topic has 0 replies, 1 voice, and was last updated 4 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
My Pathway: An Open Label Phase IIa Study Evaluating Trastuzumab/Pertuzumab, Erlotinib, Vemurafenib/Cobimetinib, and Vismodegib in Patients Who Have Advanced Solid Tumors With Mutations or Gene Expression Abnormalities Predictive of Response to One of These Agents
https://clinicaltrials.gov/ct2/show/NCT02091141
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.